| Code No. | BMP026 | |
| Anti-SLC2A13 (HMIT) (Human) pAb | ||
| Price | ¥69,300 | |
| Size | 50 µL | |
| Availability (in Japan) | 1-9
(In Japan at 17:33, Aug 7, 2026 in JST) |
|
| Clonality | Polyclonal | |
| Clone | Polyclonal | |
| Isotype (Immunized Animal) |
Rabbit Ig (aff.) | |
| Applications | WB 1:1,000 FCM 1:200 IC 1:200 IH 1:1,000 (Heat treatment is necessary for paraffin embedded sections.) |
|
| Immunogen (Antigen) |
Human SLC2A13-derived synthetic peptide | |
| Reactivity [Gene ID] | Human[114134] |
|
| Storage buffer | PBS/50% glycerol, pH 7.2 | |
| Storage temp. | -20°C | |
| Conjugate | Unlabeled | |
| Manufacturer | MBL | |
| Alternative names | solute carrier family 2 member 13 | |
| Background | SLC2A13, also known as HMIT (H+-myo-inositol symporter), is an odd member of the facilitatative glucose transporter family, as it specifically transports myo-inositol, not hexoses. SLC2A13 is predominantly expressed in astrocytes and neurons in the brain, suggesting that it may be involved in the control of myo-inositol brain metabolism. Dysfunctions or genetic variants of SLC2A13 associated with neuronal disorders have not yet been reported. | |
| Related products | BMP007 Anti-SLC2A1 (GLUT1) (Human) pAb BMP027 Anti-SLC2A9 (GLUT9) (Human) pAb PM035 Normal Rabbit IgG |
|
| Data | ![]() ![]() ![]() ![]() |
|
| Citations | Western Blotting
|
|
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve